ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Gutwein, Paul ^a   Schramme, Anja ^b   Abdel Bakky, Mohamed Sadek ^a   Doberstein, Kai ^a   Hauser, Ingeborg A ^a   Ludwig, Andreas ^c   Altevogt, Peter ^d   Gauer, Stefan ^a   Hillmann, Anja ^e   Weide, Thomas ^e   Jespersen, Christine ^a   Eberhardt, Wolfgang ^a   Pfeilschifter, Josef ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; CELL ADHESION MOLECULE; CELL ADHESION MOLECULE L1; METALLOPROTEINASE INHIBITOR; NOTCH RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ADAM10 PROTEIN, HUMAN; MEMBRANE PROTEIN; SECRETASE;

ADULT; AGED; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SPECIFICITY; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY PARENCHYMA; MALE; PODOCYTE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION; TISSUE SECTION; URINALYSIS; URINE; WESTERN BLOTTING; CELL LINE; CYTOLOGY; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GLOMERULUS; KIDNEY DISEASE; METABOLISM; MIDDLE AGED;

ADAM PROTEINS; ADULT; AGED; AMYLOID PRECURSOR PROTEIN SECRETASES; CELL LINE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PODOCYTES; RNA, SMALL INTERFERING; URINE;

EID: 77649311126     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-3     Document Type: Article

References (28)

1. Podocyte biology and response to injury. P Mundel SJ Shankland, J Am Soc Nephrol 2002 13 3005 3015
2. The podocyte: a major player in the development of diabetic nephropathy? SM Marshall, Horm Metab Res 2005 37 Suppl 1 9 16
3. The cell adhesion molecule L1 is developmentally regulated in the renal epithelium and is involved in kidney branching morphogenesis. H Debiec EI Christensen PM Ronco, J Cell Biol 1998 143 2067 2079
4. ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. P Gutwein S Mechtersheimer S Riedle A Stoeck D Gast S Joumaa H Zentgraf M Fogel DP Altevogt, FASEB J 2003 17 292 294
5. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. S Mechtersheimer P Gutwein N Agmon-Levin A Stoeck M Oleszewski S Riedle R Postina F Fahrenholz M Fogel V Lemmon P Altevogt, J Cell Biol 2001 155 661 673
6. Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. M Moos R Tacke H Scherer D Teplow K Fruh M Schachner, Nature 1988 334 701 703
7. Plasmin-sensitive dibasic sequences in the third fibronectin-like domain of L1-cell adhesion molecule (CAM) facilitate homomultimerization and concomitant integrin recruitment. S Silletti F Mei D Sheppard AM Montgomery, J Cell Biol 2000 149 1485 1502
8. The proprotein convertase PC5A and a metalloprotease are involved in the proteolytic processing of the neural adhesion molecule L1. I Kalus B Schnegelsberg NG Seidah R Kleene M Schachner, J Biol Chem 2003 278 10381 10388
9. The L1 cell adhesion molecule is a potential biomarker of human distal nephron injury in acute tubular necrosis. Y Allory V Audard P Fontanges P Ronco H Debiec, Kidney Int 2008 73 751 758
10. Changes in gene expression patterns in the ureteric bud and metanephric mesenchyme in models of kidney development. RO Stuart KT Bush SK Nigam, Kidney Int 2003 64 1997 2008
11. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. P Gutwein MS Abdel-Bakky A Schramme K Doberstein N Kampfer-Kolb K Amann IA Hauser N Obermuller C Bartel AA Abdel-Aziz eS El Sayed J Pfeilschifter, Am J Pathol 2009 174 2061 2072
12. Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney. A Schramme MS Abdel-Bakky P Gutwein N Obermuller PC Baer IA Hauser A Ludwig S Gauer L Schafer E Sobkowiak P Altevogt M Koziolek E Kiss HJ Grone R Tikkanen I Goren H Radeke J Pfeilschifter, Kidney Int 2008 74 328 338
13. ADAM10 as a target for anti-cancer therapy. ML Moss A Stoeck W Yan PJ Dempsey, Curr Pharm Biotechnol 2008 9 2 8
14. Ectopic notch activation in developing podocytes causes glomerulosclerosis. AM Waters MY Wu T Onay J Scutaru J Liu CG Lobe SE Quaggin TD Piscione, J Am Soc Nephrol 2008 19 1139 1157
15. The Notch pathway in podocytes plays a role in the development of glomerular disease. T Niranjan B Bielesz A Gruenwald MP Ponda JB Kopp DB Thomas K Susztak, Nat Med 2008 14 290 298
16. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. A Ludwig C Hundhausen MH Lambert N Broadway RC Andrews DM Bickett MA Leesnitzer JD Becherer, Comb Chem High Throughput Screen 2005 8 161 171
17. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. MA Saleem MJ O'Hare J Reiser RJ Coward CD Inward T Farren CY Xing L Ni PW Mathieson P Mundel, J Am Soc Nephrol 2002 13 630 638
18. Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. P Gutwein M Oleszewski S Mechtersheimer N Agmon-Levin K Krauss P Altevogt, J Biol Chem 2000 275 15490 15497
19. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. P Gutwein A Stoeck S Riedle D Gast S Runz TP Condon A Marme MC Phong O Linderkamp A Skorokhod P Altevogt, Clin Cancer Res 2005 11 2492 2501
20. Glomerular cell culture. GE Striker LJ Striker, Lab Invest 1985 53 122 131 3894792
21. Urinary detection of podocyte injury. M Camici, Biomed Pharmacother 2007 61 245 249
22. Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. A Petermann J Floege, Nephron Clin Pract 2007 106 61 c66
23. Discovery of urinary biomarkers. T Pisitkun R Johnstone MA Knepper, Mol Cell Proteomics 2006 5 1760 1771
24. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. D Hartmann B de Strooper L Serneels K Craessaerts A Herreman W Annaert L Umans T Lubke IA Lena K von Figura P Saftig, Hum Mol Genet 2002 11 2615 2624
25. Abnormalities in neuronal process extension, hippocampal development, and the ventricular system of L1 knockout mice. GP Demyanenko AY Tsai PF Maness, J Neurosci 1999 19 4907 4920
26. Abnormal renal phenotype in L1 knockout mice: a novel cause of CAKUT. H Debiec M Kutsche M Schachner P Ronco, Nephrol Dial Transplant 2002 17 Suppl 9 42 44
27. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Y Allory Y Matsuoka C Bazille EI Christensen P Ronco H Debiec, Clin Cancer Res 2005 11 1190 1197
28. Molecular profiling of ADAM12 in human bladder cancer. C Frohlich R Albrechtsen L Dyrskjot L Rudkjaer TF Orntoft UM Wewer, Clin Cancer Res 2006 12 7359 7368